Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__88_A2,6 | Lung | Primary cancer | 3,461 | Tumor/Malignant | 41.1% | 0.96 | 0.19 |
| NSCLC_38242124__IMC__88_A2,7 | Lung | Primary cancer | 1,860 | Tumor/Malignant | 86.8% | 0.99 | 0.02 |
| NSCLC_38242124__IMC__88_A2,8 | Lung | Primary cancer | 1,169 | Stromal | 49.4% | 0.94 | 0.15 |
| NSCLC_38242124__IMC__88_A2,9 | Lung | Primary cancer | 3,898 | Tumor/Malignant | 42.3% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__88_A3,1 | Lung | Primary cancer | 2,563 | Tumor/Malignant | 45.6% | 0.87 | 0.36 |
| NSCLC_38242124__IMC__88_A3,10 | Lung | Primary cancer | 3,551 | Stromal | 34.1% | 0.76 | 0.59 |
| NSCLC_38242124__IMC__88_A3,11 | Lung | Primary cancer | 1,855 | Stromal | 31.3% | 0.89 | 0.34 |
| NSCLC_38242124__IMC__88_A3,12 | Lung | Primary cancer | 2,749 | Tumor/Malignant | 30.2% | 0.92 | 0.26 |
| NSCLC_38242124__IMC__88_A3,13 | Lung | Primary cancer | 2,710 | Tumor/Malignant | 61.1% | 0.96 | 0.12 |
| NSCLC_38242124__IMC__88_A3,14 | Lung | Primary cancer | 2,364 | Tumor/Malignant | 46.1% | 0.96 | 0.14 |
| NSCLC_38242124__IMC__88_A3,16 | Lung | Primary cancer | 3,270 | Tumor/Malignant | 58.2% | 0.96 | 0.13 |
| NSCLC_38242124__IMC__88_A3,2 | Lung | Primary cancer | 2,814 | Tumor/Malignant | 73.3% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__88_A3,3 | Lung | Primary cancer | 3,654 | Tumor/Malignant | 38.1% | 0.53 | 0.75 |
| NSCLC_38242124__IMC__88_A3,4 | Lung | Primary cancer | 3,733 | Tumor/Malignant | 82.3% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__88_A3,6 | Lung | Primary cancer | 1,653 | Tumor/Malignant | 38.5% | 0.93 | 0.19 |
| NSCLC_38242124__IMC__88_A3,7 | Lung | Primary cancer | 3,220 | Immune | 32.8% | 0.90 | 0.30 |
| NSCLC_38242124__IMC__88_A3,8 | Lung | Primary cancer | 2,029 | Tumor/Malignant | 58.7% | 0.97 | 0.07 |
| NSCLC_38242124__IMC__88_A3,9 | Lung | Primary cancer | 2,418 | Tumor/Malignant | 26.0% | 0.96 | 0.17 |
| NSCLC_38242124__IMC__88_A4,1 | Lung | Primary cancer | 2,500 | Tumor/Malignant | 37.3% | 0.58 | 0.84 |
| NSCLC_38242124__IMC__88_A4,10 | Lung | Primary cancer | 3,599 | Tumor/Malignant | 56.4% | 0.97 | 0.08 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__88_A2,6 | Lung | Primary cancer | 3,461 | Tumor/Malignant | 41.9% | 0.96 | 0.20 |
| NSCLC_38242124__IMC__88_A2,7 | Lung | Primary cancer | 1,860 | Tumor/Malignant | 85.6% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__88_A2,8 | Lung | Primary cancer | 1,169 | Stromal | 47.6% | 0.95 | 0.14 |
| NSCLC_38242124__IMC__88_A2,9 | Lung | Primary cancer | 3,898 | Tumor/Malignant | 53.0% | 0.96 | 0.14 |
| NSCLC_38242124__IMC__88_A3,1 | Lung | Primary cancer | 2,563 | Tumor/Malignant | 33.7% | 0.94 | 0.22 |
| NSCLC_38242124__IMC__88_A3,10 | Lung | Primary cancer | 3,551 | Stromal | 37.2% | 0.51 | 0.92 |
| NSCLC_38242124__IMC__88_A3,11 | Lung | Primary cancer | 1,855 | Stromal | 24.6% | 0.75 | 0.64 |
| NSCLC_38242124__IMC__88_A3,12 | Lung | Primary cancer | 2,749 | Tumor/Malignant | 24.8% | 0.96 | 0.15 |
| NSCLC_38242124__IMC__88_A3,13 | Lung | Primary cancer | 2,710 | Tumor/Malignant | 43.9% | 0.96 | 0.11 |
| NSCLC_38242124__IMC__88_A3,14 | Lung | Primary cancer | 2,364 | Tumor/Malignant | 46.2% | 0.97 | 0.14 |
| NSCLC_38242124__IMC__88_A3,16 | Lung | Primary cancer | 3,270 | Tumor/Malignant | 55.8% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__88_A3,2 | Lung | Primary cancer | 2,814 | Tumor/Malignant | 71.4% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__88_A3,3 | Lung | Primary cancer | 3,654 | Tumor/Malignant | 33.7% | 0.94 | 0.27 |
| NSCLC_38242124__IMC__88_A3,4 | Lung | Primary cancer | 3,733 | Tumor/Malignant | 77.8% | 1.00 | 0.01 |
| NSCLC_38242124__IMC__88_A3,6 | Lung | Primary cancer | 1,653 | Tumor/Malignant | 35.6% | 0.95 | 0.15 |
| NSCLC_38242124__IMC__88_A3,7 | Lung | Primary cancer | 3,220 | Lymphoid | 25.0% | 0.59 | 0.87 |
| NSCLC_38242124__IMC__88_A3,8 | Lung | Primary cancer | 2,029 | Tumor/Malignant | 58.9% | 0.97 | 0.08 |
| NSCLC_38242124__IMC__88_A3,9 | Lung | Primary cancer | 2,418 | Tumor/Malignant | 26.1% | 0.96 | 0.17 |
| NSCLC_38242124__IMC__88_A4,1 | Lung | Primary cancer | 2,500 | Tumor/Malignant | 34.0% | 0.58 | 0.83 |
| NSCLC_38242124__IMC__88_A4,10 | Lung | Primary cancer | 3,599 | Tumor/Malignant | 56.4% | 0.97 | 0.08 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__88_A2,6 | Lung | Primary cancer | 3,461 | Tumor/Malignant cell | 47.8% | 0.94 | 0.26 |
| NSCLC_38242124__IMC__88_A2,7 | Lung | Primary cancer | 1,860 | Tumor/Malignant cell | 86.8% | 0.99 | 0.02 |
| NSCLC_38242124__IMC__88_A2,8 | Lung | Primary cancer | 1,169 | Fibroblast | 45.8% | 0.94 | 0.15 |
| NSCLC_38242124__IMC__88_A2,9 | Lung | Primary cancer | 3,898 | Tumor/Malignant cell | 64.4% | 0.93 | 0.21 |
| NSCLC_38242124__IMC__88_A3,1 | Lung | Primary cancer | 2,563 | Tumor/Malignant cell | 45.3% | 0.87 | 0.36 |
| NSCLC_38242124__IMC__88_A3,10 | Lung | Primary cancer | 3,551 | Fibroblast | 31.7% | 0.72 | 0.70 |
| NSCLC_38242124__IMC__88_A3,11 | Lung | Primary cancer | 1,855 | Fibroblast | 32.0% | 0.77 | 0.57 |
| NSCLC_38242124__IMC__88_A3,12 | Lung | Primary cancer | 2,749 | Tumor/Malignant cell | 29.8% | 0.92 | 0.25 |
| NSCLC_38242124__IMC__88_A3,13 | Lung | Primary cancer | 2,710 | Tumor/Malignant cell | 61.1% | 0.96 | 0.12 |
| NSCLC_38242124__IMC__88_A3,14 | Lung | Primary cancer | 2,364 | Tumor/Malignant cell | 50.5% | 0.96 | 0.19 |
| NSCLC_38242124__IMC__88_A3,16 | Lung | Primary cancer | 3,270 | Tumor/Malignant cell | 58.6% | 0.97 | 0.14 |
| NSCLC_38242124__IMC__88_A3,2 | Lung | Primary cancer | 2,814 | Tumor/Malignant cell | 79.4% | 0.97 | 0.11 |
| NSCLC_38242124__IMC__88_A3,3 | Lung | Primary cancer | 3,654 | Tumor/Malignant cell | 41.1% | 0.92 | 0.34 |
| NSCLC_38242124__IMC__88_A3,4 | Lung | Primary cancer | 3,733 | Tumor/Malignant cell | 82.9% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__88_A3,6 | Lung | Primary cancer | 1,653 | Tumor/Malignant cell | 41.6% | 0.91 | 0.23 |
| NSCLC_38242124__IMC__88_A3,7 | Lung | Primary cancer | 3,220 | T cell | 31.6% | 0.67 | 0.72 |
| NSCLC_38242124__IMC__88_A3,8 | Lung | Primary cancer | 2,029 | Tumor/Malignant cell | 58.8% | 0.97 | 0.08 |
| NSCLC_38242124__IMC__88_A3,9 | Lung | Primary cancer | 2,418 | Tumor/Malignant cell | 32.9% | 0.92 | 0.28 |
| NSCLC_38242124__IMC__88_A4,1 | Lung | Primary cancer | 2,500 | Tumor/Malignant cell | 48.7% | 0.80 | 0.53 |
| NSCLC_38242124__IMC__88_A4,10 | Lung | Primary cancer | 3,599 | Tumor/Malignant cell | 55.0% | 0.97 | 0.07 |